Brief: Mendus To Receive Final Payment As Result Of Completion Of The EU Horizon 2020 AML-Vaccin Project

Mendus AB (publ)

12/10/2022 07:04

Oct 12 (Reuters) - Mendus AB (publ)  IMMUN.ST :
    * REG-MENDUS AB: MENDUS TO RECEIVE FINAL PAYMENT AS A RESULT
OF
THE COMPLETION OF THE EU HORIZON 2020 AML-VACCIN PROJECT
    * WILL RECEIVE EUR 1.69 MILLION (APPROXIMATELY SEK 18
MILLION) AS
FINAL GRANT PAYMENT FROM HORIZON 2020-FUNDED AML-VACCIN PROJECT
    * ALL REQUIREMENTS FOR FINAL TRANCHE HAVE BEEN FULFILLED,
BRINGING
TOTAL FINANCIAL CONTRIBUTION FROM EUROPEAN COMMISSION TO EUR 6.0
MILLION FOR PROJECT AS A WHOLE
    * ONGOING ADVANCE II TRIAL IS A DIRECT RESULT OF THIS
HIGH-QUALITY
CONSORTIUM AND WILL CONTINUE TO DELIVER DATA, WITH A
COMPREHENSIVE SURVIVAL DATA UPDATE EXPECTED IN DECEMBER 2022

Source text for Eikon:  ID:nGNE1hsNLv 
Further company coverage:  IMMUN.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))